Home Headlines World US secures 100 million doses of potential Covid-19 vaccine for $1.95 billion...

US secures 100 million doses of potential Covid-19 vaccine for $1.95 billion – world news


Pfizer Inc and German biotech firm BioNTech SE will get $1.95 billion from the US government to produce and deliver 100 million doses of their Covid-19 vaccine candidate, the companies said on Wednesday.

The agreement allows the US government to acquire an additional 500 million doses, the Department of Health and Human Services and the Department of Defense said.

Follow latest updates on coronavirus here

The Trump administration has agreed to spend billions of dollars for the development and procurement of a potential vaccine. The administration launched ‘Operation Warp Speed’ — a joint HHS and Department of Defense program — to accelerate the development of coronavirus vaccines, treatments and diagnostics.

More than 150 coronavirus vaccines using a variety of technologies are in development globally, with some two dozen already in human trials. Governments have signed deals with drugmakers to secure the supply of various vaccine candidates.

Click here for complete coronavirus coverage

The aim is to produce vaccines that can end the pandemic by protecting billions of people from infection or severe illness.

Pfizer and BioNTech’s vaccine candidate is among those that are set to be tested in a large trial. The vaccine has shown promise in early-stage small studies in humans.

Pfizer will deliver the doses if the product receives Emergency Use Authorization or licensure from the U.S. Food and Drug Administration, after completing demonstration of safety and efficacy in a large Phase 3 clinical trial.

The companies said they expect to be ready to seek some form of regulatory approval as early as October, if the ongoing studies are successful.

Pfizer and BioNTech currently expect to manufacture up to 100 million doses globally by the end of 2020, and potentially more than 1.3 billion doses by the end of 2021, subject to final dose selection from their clinical trial.

Pfizer’s shares rose 4%, while BioNTech’s US-listed shares were up about 6% before the bell.

Stay tune

110FansLike
400FollowersFollow

Most Popular

US helps India, China protests; Decision within the US Congress

The USA has lauded India's aggression in opposition to China within the wake of the Line of Management (LoC) battle in Ladakh.

In 24 hours, 1,007 individuals died and 64,553 new circumstances had...

The variety of coronary coronary heart illness sufferers within the nation is growing quickly. Greater than 60,000 coronary coronary heart illness sufferers...

Terrorist assault in Jammu and Kashmir, two policemen martyred; Search operation...

A police convoy has been attacked in Jammu and Kashmir. The assault happened within the Naugaon sector of Srinagar. Two policemen have...

Prashant Bhushan convicted of contempt of Supreme Courtroom, sentenced on August...

Senior lawyer Prashant Bhushan has been convicted by the Supreme Courtroom of contempt of courtroom. A photograph of Chief Justice Sharad Bobade...

Nishan-e-Pakistan award for separatist chief Syed Ali Shah Geelani in Jammu...

Former Hurriyat and separatist chief Syed Ali Shah Geelani has been honored by Pakistan on its Independence Day. On Friday, August 14,...

6 members of Mirza’s household together with BJP MLA contracted coronary...

Incumbent BJP MLA from Sangli-Miraj assembly constituency and former social justice minister Suresh Khade has contracted coronary heart disease.

One jawan martyred, one injured in Naxal firing in Gadchiroli

Gadchiroli: One policeman was killed and one other injured when Naxals opened fireplace on two jawans who had been on their option...

Swami was livid over the Air India sale supply to the...

Stated "If the deal goes forward, I'll file a felony criticism towards bigwigs within the authorities."